British Hair and Nail Society Findings on Hair and Nail Disorders
July 2016
in “
British Journal of Dermatology
”
frontal fibrosing alopecia FFA folliculitis decalvans FD triple antibiotic regimen transillumination digital mucous cysts onychoheterotopia retronychia discoid lupus erythematosus DLE laser hair depilation spontaneous repigmentation androgens Lichen planopilaris LPP congenital alopecia Temporal Triangular Alopecia TTA triple-X syndrome facial hyperpigmentation lichen planus pigmentosus LPPigm laser hair removal
TLDR Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.
The document from 2016 presents findings from various studies and cases related to hair and nail disorders. A notable study included 17 men with frontal fibrosing alopecia (FFA) and 73 control subjects, revealing a strong association between FFA and the use of leave-on facial cosmetics, especially sunscreens. It showed that 100% of men with FFA used facial moisturizers regularly, with a significant number using them daily, compared to a much smaller percentage in the control group. The document also highlights a pilot study on folliculitis decalvans (FD) treated with a triple antibiotic regimen in five patients, the use of transillumination for diagnosing digital mucous cysts, and various cases including onychoheterotopia, retronychia, and the coexistence of FFA with discoid lupus erythematosus. Additionally, it discusses the coexistence of FFA and DLE, the use of laser hair depilation in FD, spontaneous repigmentation of white hair, the role of androgens in FFA, Lichen planopilaris (LPP) after hair transplant surgery, and congenital alopecia cases. Lastly, it reports on Temporal Triangular Alopecia (TTA) associated with triple-X syndrome and an unusual presentation of FFA with facial hyperpigmentation in a patient, suggesting a possible spectrum that includes lichen planus pigmentosus (LPPigm). The document emphasizes the need for further studies on the efficacy and safety of treatments for FD and increased awareness of conditions like retronychia.
